Login to Your Account

VaxGen Wins $878M BioShield Contract For Anthrax Vaccine

By Karen Pihl-Carey

Monday, November 8, 2004
Just a few days after the re-election of President Bush, the U.S. government awarded VaxGen Inc. an $877.5 million contract to supply anthrax vaccine for civilian defense. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription